Monday Aug 25
this story a-o
In January, CytoScan Dx Assay became the first and only CMA to gain clearance by the US Food and Drug Administration .
Affymetrix Receives "Outperform" Rating from Zacks
's stock had its "outperform" rating reissued by Zacks in a report released on Tuesday.
Life Sciences Tools and Services Stocks in Motion -- Affymetrix,...
The gains were broad based as six out of ten sectors ended the session in positive.
Affymetrix Given Consensus Recommendation of "Hold" by Brokerages
Shares of Affymetrix have earned an average rating of "Hold" from the eight ratings firms that are covering the company, Analyst Ratings Network reports .
Affymetrix PT Raised to $9.00 at Leerink Swann
Leerink Swann's target price indicates a potential upside of 7.27% from the company's current price.